.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Moodys
Teva
Accenture
McKinsey
Federal Trade Commission
UBS
Baxter
Farmers Insurance
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Saquinavir mesylate - Generic Drug Details

« Back to Dashboard

What are the generic sources for saquinavir mesylate and what is the scope of saquinavir mesylate patent protection?

Saquinavir mesylate
is the generic ingredient in one branded drug marketed by Hoffmann La Roche and Hoffmann-la Roche, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for saquinavir mesylate. Two suppliers are listed for this compound.

Pharmacology for saquinavir mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Hoffmann-la RocheINVIRASEsaquinavir mesylateTABLET;ORAL021785-001Dec 17, 2004RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Hoffmann La RocheINVIRASEsaquinavir mesylateCAPSULE;ORAL020628-001Dec 6, 1995RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: saquinavir mesylate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hoffmann La RocheINVIRASEsaquinavir mesylateCAPSULE;ORAL020628-001Dec 6, 1995► Subscribe► Subscribe
Hoffmann-la RocheINVIRASEsaquinavir mesylateTABLET;ORAL021785-001Dec 17, 2004► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Medtronic
Queensland Health
McKinsey
Mallinckrodt
Chubb
Boehringer Ingelheim
Johnson and Johnson
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot